Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Iran J Kidney Dis ; 11(1): 18-22, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-28174348

RESUMEN

INTRODUCTION: Hyperbaric oxygen (HBO) treatment is steadily increasing as a therapeutic modality for various types of diseases. Although good clinical outcomes were reported with HBO treatment for various diseases, the multisystemic effects of this modality are still unclear. This study aimed to investigate the renal effects of HBO experimentally. MATERIALS AND METHODS: Fourteen New Zealand White rabbits were divided into 2 groups randomly as the control group and the study group. The study group received HBO treatment for 28 days (100% oxygen at 2.5 atmospheres for 90 minutes daily) and the control group was used to obtain normal renal tissue of the animal genus. After the intervention period, venous blood samples were obtained, and renal tissue samples were harvested for comparisons. RESULTS: Normal histological morphology was determined with Masson trichrome staining and periodic acid-Schiff staining in the control group. Atrophic glomerular structures, vacuolated tubule cells, and degeneration were detected in the renal samples of the study group with Masson trichrome staining. Additionally, flattening was observed on the brush borders of the proximal tubules, and tubular dilatation was visualized with periodic acid-Schiff staining. The histopathologic disruption of renal morphology was verified with detection of significantly elevated kidney function laboratory biomarkers in the study group. CONCLUSIONS: Our findings suggests that HBO has adverse effects on renal glomerulus and proximal tubules. However, the functional effects of this alteration should be investigated with further studies.


Asunto(s)
Oxigenoterapia Hiperbárica/efectos adversos , Riñón , Insuficiencia Renal , Animales , Modelos Animales de Enfermedad , Riñón/efectos de los fármacos , Riñón/patología , Riñón/fisiopatología , Pruebas de Función Renal/métodos , Conejos , Insuficiencia Renal/sangre , Insuficiencia Renal/etiología , Insuficiencia Renal/patología , Estadística como Asunto
2.
Cardiovasc J Afr ; 26(6): 222-6, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26659436

RESUMEN

OBJECTIVE: Ginseng is a traditional herbal medicinal product widely used for various types of diseases because of its cellular protective effects. Possible protective effects of ginseng were investigated in blood, cardiac and renal tissue samples and compared with common anti-aggregant agents in an animal ischaemia-reperfusion (I/R) model. METHODS: Twenty rats were equally divided into four different groups as follows: control group (I/R-induced group without drug use), group I (acetylsalicylic acid-administered group), group II (clopidogrel bisulfate-administered group), group III (ginsenoside Rb1-administered group). For the groups assigned to a medication, peripheral I/R was induced by clamping the femoral artery one week after initiation of the specified medication. After reperfusion was initiated, cardiac and renal tissues and blood samples were obtained from each rat with subsequent analysis of nitrogen oxide (NOx), malondialdehyde (MDA), paraoxonase 1 (PON1) and prolidase. RESULTS: NOx levels were similar in each group. Significant decrements were observed in serum PON1 levels in each group when compared with the control (p < 0.05). Serum MDA levels were significantly lower in groups II and III (p < 0.05). Ameliorated renal prolidase levels were detected in study groups (p < 0.05) and recovered cardiac prolidase levels were obtained in groups II and III (p < 0.05). CONCLUSION: These findings indicate that ginseng extracts may have a potential beneficial effect in I/R injury. However, more comprehensive studies are required to clarify the hypothetical cardiac, renal and systemic protective effects in reperfusion-induced oxidative damage.


Asunto(s)
Aspirina/farmacología , Ginsenósidos/farmacología , Panax/química , Extractos Vegetales/farmacología , Inhibidores de Agregación Plaquetaria/farmacología , Sustancias Protectoras/farmacología , Daño por Reperfusión/prevención & control , Ticlopidina/análogos & derivados , Animales , Arildialquilfosfatasa/sangre , Biomarcadores/sangre , Clopidogrel , Dipeptidasas/sangre , Modelos Animales de Enfermedad , Arteria Femoral/cirugía , Ginsenósidos/aislamiento & purificación , Riñón/efectos de los fármacos , Riñón/metabolismo , Ligadura , Malondialdehído/sangre , Miocardio/metabolismo , Óxido Nítrico/sangre , Estrés Oxidativo/efectos de los fármacos , Fitoterapia , Extractos Vegetales/aislamiento & purificación , Plantas Medicinales , Sustancias Protectoras/aislamiento & purificación , Ratas , Daño por Reperfusión/sangre , Daño por Reperfusión/etiología , Ticlopidina/farmacología
3.
Kaohsiung J Med Sci ; 31(3): 115-22, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25744233

RESUMEN

The aim of this study was to investigate whether anticoagulant and antiaggregant agents have protective effects against oxidative damage induced by peripheral ischemia-reperfusion (I/R). Groups were created as follows: control group, I/R group (sham group), I/R plus acetylsalicylic acid (Group I), I/R+clopidogrel (Group II), I/R+rivaroxaban (Group III), I/R+bemiparin sodium (Group IV), and I/R+enoxaparin sodium (Group V). In Groups I, II, III, IV, and V, drugs were administered daily for 1 week before I/R creation. Peripheral I/R was induced in the I/R groups by clamping the right femoral artery. The rats were sacrificed 1 hour after reperfusion. Nitrogen oxide levels, malondialdehyde (MDA) levels, paraoxonase-1 (PON1) activity, and prolidase activity were evaluated in both cardiac and renal tissues. There was no significant difference in nitrogen oxide levels between the groups. However, cardiac and renal MDA were significantly higher and PON1 activity was markedly lower in the I/R groups compared with the control group (p<0.05). Although elevated prolidase activity was detected in both the cardiac and renal tissue of the I/R groups, only the sham group and Group V had significantly higher renal prolidase activity (p<0.05). Group V had significantly higher cardiac MDA, PON1, prolidase levels, and renal prolidase activity compared with the sham group (p<0.05). Significant improvement in renal MDA levels was only observed in Group III, and marked improvement was observed in the cardiac MDA levels of Group II when compared with the sham group (p<0.05). Thromboprophylactic agents appear to provide partial or prominent protection against I/R injury.


Asunto(s)
Anticoagulantes/uso terapéutico , Cardiotónicos/uso terapéutico , Daño por Reperfusión/tratamiento farmacológico , Animales , Anticoagulantes/farmacología , Arildialquilfosfatasa/metabolismo , Aspirina/farmacología , Aspirina/uso terapéutico , Cardiotónicos/farmacología , Clopidogrel , Dipeptidasas/metabolismo , Evaluación Preclínica de Medicamentos , Enoxaparina/farmacología , Enoxaparina/uso terapéutico , Arteria Femoral/patología , Heparina de Bajo-Peso-Molecular/farmacología , Heparina de Bajo-Peso-Molecular/uso terapéutico , Miembro Posterior/irrigación sanguínea , Riñón/efectos de los fármacos , Riñón/metabolismo , Masculino , Malondialdehído , Morfolinas/farmacología , Morfolinas/uso terapéutico , Miocardio/metabolismo , Óxido Nítrico/metabolismo , Estrés Oxidativo , Ratas Sprague-Dawley , Daño por Reperfusión/metabolismo , Rivaroxabán , Tiofenos/farmacología , Tiofenos/uso terapéutico , Ticlopidina/análogos & derivados , Ticlopidina/farmacología , Ticlopidina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA